The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online April 16, 2007
doi:10.1084/jem.20062566
The Journal of Experimental Medicine, Vol. 204, No. 5, 1049-1056
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Sood et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3815K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sood, R.
Right arrow Articles by Weiler, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sood, R.
Right arrow Articles by Weiler, H.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers

Rashmi Sood1, Mark Zogg1, Randal J. Westrick2, Yi-he Guo1, Edward J. Kerschen1, Guillermina Girardi3, Jane E. Salmon3, Shaun R. Coughlin4, and Hartmut Weiler1

1 Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53226
2 University of Michigan, Ann Arbor, MI 48109
3 Hospital for Special Surgery and Weill Medical College, Cornell University, New York, NY 10021
4 Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143

CORRESPONDENCE Rashmi Sood: Rashmi.Sood{at}bcw.edu OR Hartmut Weiler: Hartmut.Weiler{at}bcw.edu

We describe a mouse model of fetal loss in factor V Leiden (FvL) mothers in which fetal loss is triggered when the maternal prothrombotic state coincides with fetal gene defects that reduce activation of the protein C anticoagulant pathway within the placenta. Fetal loss is caused by disruption of placental morphogenesis at the stage of labyrinth layer formation and occurs in the absence of overt placental thrombosis, infarction, or perfusion defects. Platelet depletion or elimination of protease-activated receptor 4 (Par4) from the mother allows normal placentation and prevents fetal loss. These findings establish a cause–effect relationship for the observed epidemiologic association between maternal FvL status and fetal loss and identify fetal gene defects as risk modifiers of pregnancy failure in prothrombotic mothers. Pregnancy failure is mediated by Par4-dependent activation of maternal platelets at the fetomaternal interface and likely involves a pathogenic pathway independent of occlusive thrombosis. Our results further demonstrate that the interaction of two given thrombosis risk factors produces markedly disparate consequences on disease manifestation (i.e., thrombosis or pregnancy loss), depending on the vascular bed in which this interaction occurs.


Abbreviations used: dpc, days post coitum; FvL, factor V Leiden; Par4, protease-activated receptor 4; Procr, endothelial protein C receptor; TAT, thrombin–antithrombin; Tfpi, tissue factor pathway inhibitor; Thbd, thrombomodulin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Avoiding fetal loss
Hema Bashyam
J. Exp. Med. 2007 204: 966a. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS